ClinicalTrials.Veeva

Menu

Efficacy of Urinary Follicle-Stimulating Hormone (FSH) Among Poor Responders

G

German Hospital, Istanbul

Status

Unknown

Conditions

Infertility

Treatments

Drug: Fostimon

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We proposed to compare outcomes in women with DOR undergoing ART with rec-FSH + u-HMH with those with u-FSH only in GnRH antagonist protocols.

Sex

Female

Ages

20 to 44 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • At least one trial with adequate ovarian stimulation resulted by 4 or less oocytes retrieval.

Exclusion criteria

  • High responder patients

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 1 patient group

UrFSH
Active Comparator group
Treatment:
Drug: Fostimon

Trial contacts and locations

1

Loading...

Central trial contact

Mustafa Bahceci, M.D; Ulun Ulug, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems